跳至主要内容
临床试验/NCT01379742
NCT01379742Unknown4 期

Comparison of Health Related Quality of Life and Other Clinical Parameters Between ThinSeed™ and OncoSeed™ for Permanent Low Dose Rate Implantation in Localized Prostate Cancer

Prostate Cancer Foundation of Chicago2 个研究点 分布在 1 个国家目标入组 240 人开始时间: 2010年4月1日最近更新:
适应症

试验速览

阶段
4 期
发起方
入组人数
240
试验地点
2
主要终点
Health related quality of life including urinary, bowel and sexual function as measured by the EPIC questionnaire

研究概览

简要总结

This study will investigate health related quality of life factors in patients undergoing low dose rate prostate brachytherapy. Patients will be randomized to Iodine-125 Thinstrand (for use with 20 g needles) or Rapidstrand (for use with standard 18 g needles). Urinary, bowel, sexual function and bother will be measured by the EPIC questionnaire at various time intervals.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Histologically confirmed adenocarcinoma of the prostate, clinical stage T1c - T2b, N0, M0
  • Greater than or equal to 40 years of age
  • Low and Low- Intermediate Risk prostate cancer
  • Prostate volumes by TRUS ≤ 60 cc
  • I-PSS score < 25 (alpha blockers allowed)
  • Signed study-specific informed consent form prior to study entry

排除标准

  • Lymph node involvement (N1)
  • Evidence of distant metastases (M1)
  • Radical surgery for carcinoma of the prostate
  • Prior pelvic radiation
  • Major medical or psychiatric illness, which in the investigator's opinion would prevent completion of treatment and would interfere with follow- up or ability to complete questionnaires
  • Hip prosthesis
  • Inability or refusal to provide informed consent
  • Evidence of Previous TURP
  • Prior hormone therapy
  • Prior TURP

结局指标

主要结局

Health related quality of life including urinary, bowel and sexual function as measured by the EPIC questionnaire

时间窗: 1 year

Randomized

次要结局

未报告次要终点

研究者

发起方
Prostate Cancer Foundation of Chicago
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验